| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.41 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |